Global Market Estimates Strategic Insights - Beating The Pandemic's
Effect On Your Revenues
Global Clinical Decision Support Systems Market Size, Trends & Analysis - Forecasts to 2026 By Type of CDSS (Standalone CDSS & Integrated CDSS), By Delivery Mode (On-Premise, and Cloud-Based), By Component (Software, Hardware, and Service), By End-User (In-Patient Setting, Out-Patient Setting and Other End Users), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis
Clinical Decision Support Systems Market Insights
A healthcare information-based technology that helps doctors and other healthcare providers in deciding healthcare management is called clinical decision support systems. The technology is designed and equipped with clinical decision-making tasks. With the augmentation of such technology, events and cases such as medication management based error, failure in the drug treatment process, mistakes in prescription and administration of drugs are getting ruled out and helping decision-makers with the error-free drug administration process.
Rapidly changing trend of adopting IT solutions and software in the healthcare industry through government regulations and support, increasing number of chronic patients worldwide, rising interest of end-users to adopt CDSS-enabled EHRs, increasing number of organic growth strategies amongst major players to promote and expand their business in niche markets, increasing cases of data mishandling clubbed with data error issues, and the increasing trend of using big data analysis, Artificial Intelligence, and mHealth, will propel the market growth during the forecast period.
Clinical Decision Support Systems Market: By Type of CDSS
The market can be segregated into standalone and integrated clinical decision support systems. Standalone CDSS segment is analysed to be the largest market share holder owing to its high level of simplicity, high productivity &adoption rate, and pocket-friendliness to hospitals and ambulatory care centers.
Clinical Decision Support Systems Market: By Delivery Mode
The delivery mode for such technology comes in two ways, namely On-Premise, and Cloud-based. The On-Premise based delivery mode will be the largest segment in the CDSS market. The major reason being data security assurance offered by On-Premise based delivery model.
Clinical Decision Support Systems Market: By Component
Software, services, and hardware are the major three components of CDSS technology in the market. The market for services is analysed to be the fastest growing component segment during the forecast period. The high growth rate of this segment is attributed to the launch and adoption of new upgraded software, and the constant need for post-sale training-based services for existing software. Its high cost will in turn help in revenue generation for the market
Clinical Decision Support Systems Market: By End User
In-patient, and out-patient settings are the major two end users of the market. The in-patient setting has contributed the most in 2019 and is expected to be a constantly higher revenue generator than the out-patient setting from 2020 to 2026 for the CDSS market. Large patient volume data generated, and an increasing number of patient administration in the IPD settings are the major reasons for its dominance in the market.
Clinical Decision Support Systems Market: By Region
As of 2019, North America is estimated to be the largest market by region for CDSS technology. However, from 2020 to 2026, it is estimated that the Asia Pacific region will be growing faster than North American, European, Middle East & South African, and Central & South American regions, owing to major drivers such asthe high presence of geriatric patient population, increasing burden of lifestyle disorder, rising awareness on digitization, and increasing government support for merging AI and healthcare in countries like China, Japan, Malaysia, India, and Australia.
Clinical Decision Support Systems Market Share and Competitor Analysis
Siemens Healthineers, Allscripts Healthcare Solutions, IBM Watson Health, Wolters Kluwer Health, Epic, MEDITECH, Zynx Health, Elsevier B.V., NextGen Healthcare, and Cerneramong others are the prime players of the market.
Please note: This is not an exhaustive list of companies profiled in the report.
In 2019, Cerner entered into an exclusive partnership and collaboration with Tenet Healthcare to install Cerner’s IT software and technology across hospitals and clinics for decision-making tasks.
Check the Press Release on Global Clinical Decision Support Systems Market Report
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Clinical Decision Support Systems Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Clinical Decision Support Systems Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
A dedicated client engagement team for round the clock support in terms of requirement gathering, query handling, and any other support activity.
More than 50% of innovation comes from the voice of the customer through which our analysts find blindspots in your revenue decisions.
The best vision is actionable insights across high growth markets with GMEs disruptive research methodology.
Disruptive research that correlates markets, technologies, new use cases and companies.
80% of Fortune 2000 use GME for their growth strategies.
Get in-depth analysis of the COVID-19 impact on this study
Benchmarking the rapid strategy shifts of the Top 100 companies in this market space
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
